EE05491B1 - Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena - Google Patents

Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena

Info

Publication number
EE05491B1
EE05491B1 EEP200100661A EEP200100661A EE05491B1 EE 05491 B1 EE05491 B1 EE 05491B1 EE P200100661 A EEP200100661 A EE P200100661A EE P200100661 A EEP200100661 A EE P200100661A EE 05491 B1 EE05491 B1 EE 05491B1
Authority
EE
Estonia
Prior art keywords
composition
pharmaceutical product
nutritional supplement
alkaline sphingomyelinase
dietetic preparation
Prior art date
Application number
EEP200100661A
Other languages
English (en)
Estonian (et)
Inventor
De Simone Claudio
Original Assignee
Vsl Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05491(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vsl Pharma Limited filed Critical Vsl Pharma Limited
Publication of EE200100661A publication Critical patent/EE200100661A/xx
Publication of EE05491B1 publication Critical patent/EE05491B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04012—Sphingomyelin phosphodiesterase (3.1.4.12)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
EEP200100661A 1999-06-09 2000-06-07 Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena EE05491B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000376A IT1311495B1 (it) 1999-06-09 1999-06-09 Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
PCT/IT2000/000230 WO2000074712A2 (en) 1999-06-09 2000-06-07 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product

Publications (2)

Publication Number Publication Date
EE200100661A EE200100661A (et) 2003-04-15
EE05491B1 true EE05491B1 (et) 2011-12-15

Family

ID=11406823

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100661A EE05491B1 (et) 1999-06-09 2000-06-07 Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena

Country Status (34)

Country Link
US (2) US20020031507A1 (pl)
EP (1) EP1181047B9 (pl)
JP (2) JP4897167B2 (pl)
KR (1) KR100812806B1 (pl)
CN (3) CN101695374B (pl)
AR (1) AR024564A1 (pl)
AT (1) ATE237350T1 (pl)
AU (1) AU778946B2 (pl)
BR (1) BR0011447A (pl)
CA (1) CA2376048C (pl)
CZ (1) CZ296369B6 (pl)
DE (1) DE60002194T3 (pl)
DK (1) DK1181047T4 (pl)
DZ (1) DZ3160A1 (pl)
EA (1) EA005166B1 (pl)
EE (1) EE05491B1 (pl)
EG (1) EG24675A (pl)
ES (1) ES2195902T5 (pl)
HK (1) HK1046246A1 (pl)
HU (1) HU228941B1 (pl)
IL (2) IL146888A0 (pl)
IS (1) IS2742B (pl)
IT (1) IT1311495B1 (pl)
MA (1) MA26792A1 (pl)
MX (1) MXPA01012641A (pl)
NO (1) NO327862B1 (pl)
PL (1) PL214675B1 (pl)
PT (1) PT1181047E (pl)
SI (1) SI1181047T2 (pl)
SK (1) SK285901B6 (pl)
TR (1) TR200103566T2 (pl)
UA (1) UA80799C2 (pl)
WO (1) WO2000074712A2 (pl)
ZA (1) ZA200200039B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
IE20011100A1 (en) * 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US9980988B2 (en) 2002-03-13 2018-05-29 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
KR100568036B1 (ko) * 2004-08-12 2006-04-07 하남주 장기능 활성화 및 면역기능 강화작용을 하는비피도박테리움 균주 및 이를 함유하는 생균제제
KR100610379B1 (ko) * 2004-08-26 2006-08-10 하남주 면역 증강 활성을 가지는 신규 유산균
TW200837194A (en) * 2007-03-06 2008-09-16 Microbio Company Ltd Taiwan Fermented panax notoginseng solution with anti-cancer effects and manufacture method thereof
KR100868777B1 (ko) * 2007-03-15 2008-11-17 재단법인서울대학교산학협력재단 Ｒｓ３ 유형의 저항 전분에 대해 분해능이 있는비피도박테리움 아도레스센티스를 유효성분으로 함유하는것을 특징으로 하는 식품 조성물
DK2270133T3 (en) 2008-04-22 2015-09-07 Corporación Alimentaria Peñasanta Capsa Method of obtaining a new strain of Bifidobacterium bidifum with effect against infection with Helicobacter pylori
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
KR101364695B1 (ko) * 2011-06-29 2014-02-19 가천대학교 산학협력단 헬리코박터 파이로리의 생육을 저해하는 타락 유래 젖산균
MX2015005165A (es) * 2012-10-25 2015-10-29 Gervais Danone Sa Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
KR101479818B1 (ko) * 2012-12-17 2015-01-26 주식회사 알엔에이 유산균 파쇄물의 제조방법
TW201630596A (zh) * 2015-01-06 2016-09-01 Meiji Co Ltd 鞘脂質吸收促進劑
CA3020578A1 (en) * 2016-04-13 2017-10-19 Meiji Co., Ltd. Composition for improving brain function for neonates
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55120787A (en) * 1979-03-09 1980-09-17 Teruhiko Beppu Preparation of sphingomyelinase
JPS60221084A (ja) * 1984-04-18 1985-11-05 Chiyoda Chem Eng & Constr Co Ltd スフインゴミエリナ−ゼの製造法
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP2676484B2 (ja) * 1994-03-28 1997-11-17 熊本県 ヨーグルト様乳酸発酵食品の製造方法
JP3122333B2 (ja) * 1995-02-28 2001-01-09 株式会社薬理学中央研究所 赤血球を原料とするスフィンゴミエリンおよびセラミドの新規製造方法とセラミド配合治療剤又は化粧品
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
JP3530674B2 (ja) * 1996-03-04 2004-05-24 明治乳業株式会社 変異原性物質吸収阻害性食品
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
JP3400282B2 (ja) * 1997-02-21 2003-04-28 株式会社ヤクルト本社 脂質代謝改善剤およびそれを含有する食品
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.

Also Published As

Publication number Publication date
CA2376048C (en) 2014-12-09
NO20016004L (no) 2002-02-06
AR024564A1 (es) 2002-10-16
EG24675A (en) 2010-04-27
US20020031507A1 (en) 2002-03-14
DK1181047T3 (da) 2003-08-11
IL146888A (en) 2012-02-29
KR100812806B1 (ko) 2008-03-12
AU5563900A (en) 2000-12-28
US20050084486A1 (en) 2005-04-21
EP1181047B2 (en) 2009-10-28
IS6178A (is) 2001-11-27
HK1046246A1 (zh) 2003-01-03
WO2000074712A2 (en) 2000-12-14
HU228941B1 (en) 2013-07-29
UA80799C2 (uk) 2007-11-12
DE60002194T2 (de) 2004-01-29
EE200100661A (et) 2003-04-15
MA26792A1 (fr) 2004-12-20
ATE237350T1 (de) 2003-05-15
SK17162001A3 (sk) 2002-03-05
CZ20014219A3 (cs) 2002-04-17
ES2195902T3 (es) 2003-12-16
WO2000074712A3 (en) 2001-05-03
CZ296369B6 (cs) 2006-02-15
CN1354672A (zh) 2002-06-19
AU778946B2 (en) 2004-12-23
DZ3160A1 (fr) 2000-12-14
SI1181047T1 (en) 2003-10-31
JP2003501399A (ja) 2003-01-14
CA2376048A1 (en) 2000-12-14
JP2012040015A (ja) 2012-03-01
DE60002194D1 (de) 2003-05-22
CN101352234A (zh) 2009-01-28
SK285901B6 (sk) 2007-10-04
EP1181047B1 (en) 2003-04-16
ES2195902T9 (es) 2011-03-01
NO327862B1 (no) 2009-10-05
SI1181047T2 (sl) 2010-02-26
TR200103566T2 (tr) 2002-05-21
DE60002194T3 (de) 2010-02-25
PL214675B1 (pl) 2013-09-30
CN101695374A (zh) 2010-04-21
JP4897167B2 (ja) 2012-03-14
NO20016004D0 (no) 2001-12-07
HUP0201631A3 (en) 2006-02-28
ZA200200039B (en) 2002-12-24
EA200200019A1 (ru) 2002-06-27
HUP0201631A2 (hu) 2005-12-28
PT1181047E (pt) 2003-09-30
EA005166B1 (ru) 2004-12-30
KR20020016826A (ko) 2002-03-06
PL364729A1 (pl) 2004-12-13
EP1181047A2 (en) 2002-02-27
IS2742B (is) 2011-06-15
EP1181047B9 (en) 2010-08-25
ES2195902T5 (es) 2010-02-18
BR0011447A (pt) 2002-03-19
DK1181047T4 (da) 2010-03-15
ITRM990376A1 (it) 2000-12-09
IT1311495B1 (it) 2002-03-13
IL146888A0 (en) 2002-08-14
ITRM990376A0 (it) 1999-06-09
CN101695374B (zh) 2015-08-19
MXPA01012641A (es) 2004-03-19

Similar Documents

Publication Publication Date Title
EE05491B1 (et) Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena
GB9916536D0 (en) Nutritional or pharmaceutical compositions
HK1046134A1 (en) Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them.
MXPA01004876A (es) Producto comestible refrescante de aliento.
HUP0004040A3 (en) Pleuromutilin derivatives as antimicrobials, process for their preparation, pharmaceutical compositions, comprising thereof and their use
IL148876A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
ZA200200743B (en) Preserved pharmaceutical formulations.
HUP0102766A3 (en) Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
IL145665A (en) Carbamic acid derivatives, their preparation and pharmaceutical compositions comprising them
IL137332A (en) Benzothiadiazoles and derivatives, their preparation and pharmaceutical compositions comprising them
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
HUP0203627A3 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them
IT1283478B1 (it) Composizioni per integrazione nutrizionale comprendenti vitamine idrosolubili a rilascio prolungato
HK1050003A1 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them.
HUP0303455A3 (en) Imidazolidine derivatives, their preparation and pharmaceutical compositions containing them
ZA994696B (en) Nutritional healthcare formulation.
HUP0203454A3 (en) Novel fusidic acid derivatives, pharmaceutical compositions containing them and their use
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
HUP0204117A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing them and their use
IL143800A0 (en) Halovir, an antiviral marine natural product, derivatives thereof and pharmaceutical compositions containing the same
AU3699599A (en) Composition for pharmaceutical use and/or for use as a nutrition supplement, forhumans or animals
ZA994697B (en) Pharmaceutical formulation.
ZA200002148B (en) Cereal-based product for human nutrition.

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
MM4A Lapsed by not paying the annual fees

Effective date: 20160607